In the media

21  Jan

Press review

From Monday to Friday, the Inserm press office offers a summary of the daily press (only available in French)

Today's review

What's on?

Epidémie mortelle en Chine liée à une nouvelle forme de coronavirus

Une nouvelle forme de coronavirus a fait ses premières victimes en Chine. ...

Press Releases Tous les communiqués

A New Blood Component Revealed

Does the blood we thought to know so well contain elements that had been undetectable until now? The answer is yes, according to a team ...

Meningeal Lymphatic Network: A New Avenue in the Treatment of Brain Tumors

Glioblastomas are the most common type of brain tumor, and their prognosis is often highly unfavorable. A collaborative study by Jean-Léon Thomas, Inserm researcher at ...

B Cells: New Allies in Sarcoma Immunotherapy?

An international team led by Wolf Hervé Fridman with researchers from Inserm, Sorbonne Université and Université de Paris at the Cordeliers Research Center, in collaboration ...

PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up and builds research capacity against deadly disease

PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up and builds research capacity against deadly disease ...

Videos

Quatre cafés par jour, vraiment ?

Informations multiples

News in brief

Publications

 
Inserm by the numbers
With a budget of 957 million euros in 2017, Inserm supports more than 300 laboratories across France.
Inserm by the numbers
fermer
fermer
RSS Youtube